Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)
China flag China · Delayed Price · Currency is CNY
15.93
+0.23 (1.46%)
Feb 3, 2026, 3:04 PM CST

SHE:002755 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
1,3851,4111,047772.711,1661,369
Trading Asset Securities
1,091683.28713.83839.08522.39100
Cash & Short-Term Investments
2,4762,0951,7611,6121,6881,469
Cash Growth
18.86%18.96%9.25%-4.51%14.90%14.14%
Accounts Receivable
293.43231.83181.24323.03581.86968.27
Other Receivables
8.4113.0249.8825.2116.2924.79
Receivables
301.84244.85231.12348.23598.15993.06
Inventory
126.88196.99167.49141.53141.84168.74
Other Current Assets
36.9631.592736.5659.1416.01
Total Current Assets
2,9412,5682,1862,1382,4872,647
Property, Plant & Equipment
423.21474.03478.4547.14658.33706.66
Long-Term Investments
48.33118.72118.21107.57105.1877.36
Other Intangible Assets
547.22146.3498.3495.7797.6984.91
Long-Term Deferred Tax Assets
24.6624.6225.7325.8528.6926.9
Long-Term Deferred Charges
409.57676.78563.46453.7342.02257.47
Other Long-Term Assets
41.7238.9753.2646.225.757.89
Total Assets
4,4364,0483,5243,4143,7253,808
Accounts Payable
40.9559.9838.2939.0865.7295.29
Accrued Expenses
9.7440.8443.6119.56133.48299.13
Short-Term Debt
4762114.0245.03-20.01
Current Portion of Leases
2.334.063.033.452.61-
Current Income Taxes Payable
20.292.053.592.137.5413.14
Current Unearned Revenue
230.95108.5115.8811.6815.2631.18
Other Current Liabilities
732.08543.53213.14102.81177.11231.23
Total Current Liabilities
1,083820.96431.55323.74401.71689.99
Long-Term Leases
3.856.626.758.9211.52-
Long-Term Unearned Revenue
60.3260.6664.7255.8168.9369.41
Long-Term Deferred Tax Liabilities
17.1517.1510.1812.5615.0815.49
Total Liabilities
1,165905.39513.2401.03497.24774.89
Common Stock
928.16928.16928.16928.16928.16928.16
Additional Paid-In Capital
164.17136.94136.9450.730.941.49
Retained Earnings
2,1011,9891,8281,9772,2952,101
Comprehensive Income & Other
11.978.956.587.25-5.9-3.7
Total Common Equity
3,2053,0632,9002,9633,2193,027
Minority Interest
66.7379.59110.750.378.826.06
Shareholders' Equity
3,2723,1423,0113,0133,2283,033
Total Liabilities & Equity
4,4364,0483,5243,4143,7253,808
Total Debt
53.1872.67123.857.4114.1320.01
Net Cash (Debt)
2,4232,0221,6371,5541,6741,449
Net Cash Growth
22.34%23.52%5.32%-7.14%15.51%12.58%
Net Cash Per Share
2.522.141.761.651.811.57
Filing Date Shares Outstanding
928.16928.16928.16928.16928.16928.16
Total Common Shares Outstanding
928.16928.16928.16928.16928.16928.16
Working Capital
1,8581,7471,7551,8142,0851,957
Book Value Per Share
3.453.303.123.193.473.26
Tangible Book Value
2,6582,9162,8022,8673,1212,942
Tangible Book Value Per Share
2.863.143.023.093.363.17
Buildings
-385.96375.5371.29437.94436.85
Machinery
-804.36744.21767.2776.51764.36
Construction In Progress
-23.5136.0729.819.7115.72
Source: S&P Global Market Intelligence. Standard template. Financial Sources.